Titan Biotech Ltd
BSE:524717
Titan Biotech Ltd
BSE:524717
Price:
415.85
INR
3.92%
Market Closed
Market Cap:
₹17.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Titan Biotech Ltd
BSE:524717
|
IN |
|
Harena Resources PLC
OTC:CRMNF
|
UK |
|
Pratama Widya Tbk PT
IDX:PTPW
|
ID |
|
Everlon Financials Ltd
BSE:514358
|
IN |
|
Nikkiso Co Ltd
TSE:6376
|
JP |
Cash Flow Statement
Cash Flow Statement
Titan Biotech Ltd
Titan Biotech Ltd
Currency: INR
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||
| Net Income |
382
|
392
|
427
|
386
|
382
|
371
|
290
|
322
|
330
|
281
|
252
|
315
|
305
|
244
|
275
|
|
| Depreciation & Amortization |
27
|
18
|
22
|
23
|
25
|
27
|
24
|
26
|
26
|
26
|
30
|
33
|
38
|
42
|
44
|
|
| Other Non-Cash Items |
34
|
20
|
19
|
19
|
19
|
18
|
12
|
13
|
13
|
11
|
13
|
14
|
14
|
11
|
8
|
|
| Cash Taxes Paid |
48
|
67
|
109
|
117
|
127
|
117
|
71
|
87
|
81
|
75
|
68
|
79
|
77
|
60
|
60
|
|
| Cash Interest Paid |
32
|
18
|
0
|
17
|
16
|
16
|
0
|
0
|
0
|
7
|
6
|
12
|
12
|
8
|
6
|
|
| Change in Working Capital |
(244)
|
(199)
|
(278)
|
(224)
|
(240)
|
(280)
|
(104)
|
(187)
|
(201)
|
(106)
|
(72)
|
(151)
|
(125)
|
(95)
|
(119)
|
|
| Cash from Operating Activities |
199
N/A
|
231
+16%
|
191
-18%
|
205
+7%
|
186
-9%
|
136
-27%
|
220
+62%
|
174
-21%
|
168
-4%
|
212
+26%
|
224
+6%
|
211
-6%
|
233
+10%
|
201
-13%
|
208
+3%
|
|
| Investing Cash Flow | ||||||||||||||||
| Capital Expenditures |
(57)
|
(22)
|
(49)
|
(130)
|
(140)
|
(231)
|
(137)
|
(110)
|
(126)
|
(132)
|
(145)
|
(197)
|
(209)
|
(94)
|
(58)
|
|
| Other Items |
(40)
|
(57)
|
0
|
3
|
25
|
38
|
(28)
|
(27)
|
(26)
|
(76)
|
(56)
|
(6)
|
99
|
(4)
|
(254)
|
|
| Cash from Investing Activities |
(97)
N/A
|
(79)
+19%
|
(49)
+38%
|
(127)
-162%
|
(115)
+10%
|
(193)
-68%
|
(164)
+15%
|
(136)
+17%
|
(151)
-11%
|
(207)
-37%
|
(201)
+3%
|
(203)
-1%
|
(110)
+46%
|
(99)
+10%
|
(312)
-216%
|
|
| Financing Cash Flow | ||||||||||||||||
| Net Issuance of Debt |
(2)
|
(83)
|
(81)
|
(66)
|
(81)
|
60
|
(20)
|
(12)
|
31
|
(4)
|
12
|
(2)
|
(60)
|
(55)
|
62
|
|
| Cash Paid for Dividends |
(8)
|
(8)
|
(8)
|
(8)
|
(12)
|
(12)
|
(12)
|
(12)
|
(12)
|
(12)
|
(15)
|
(15)
|
(17)
|
(17)
|
(17)
|
|
| Other |
(32)
|
(18)
|
(17)
|
(17)
|
(16)
|
(16)
|
(9)
|
46
|
48
|
(7)
|
(10)
|
(12)
|
(12)
|
(8)
|
(6)
|
|
| Cash from Financing Activities |
(42)
N/A
|
(109)
-157%
|
(106)
+3%
|
(91)
+14%
|
(109)
-20%
|
32
N/A
|
(41)
N/A
|
21
N/A
|
66
+218%
|
(24)
N/A
|
(12)
+49%
|
(29)
-135%
|
(88)
-206%
|
(80)
+9%
|
39
N/A
|
|
| Change in Cash | ||||||||||||||||
| Net Change in Cash |
60
N/A
|
44
-27%
|
36
-17%
|
(14)
N/A
|
(38)
-183%
|
(25)
+35%
|
15
N/A
|
59
+293%
|
83
+40%
|
(20)
N/A
|
11
N/A
|
(20)
N/A
|
35
N/A
|
23
-34%
|
(64)
N/A
|
|
| Free Cash Flow | ||||||||||||||||
| Free Cash Flow |
142
N/A
|
209
+48%
|
142
-32%
|
75
-48%
|
46
-38%
|
(95)
N/A
|
84
N/A
|
65
-23%
|
42
-35%
|
80
+91%
|
79
-1%
|
15
-82%
|
24
+62%
|
107
+352%
|
150
+41%
|
|
Switch to:
Switch to:
See Also
Discover More
